title: Severe EBV hepatitis treated with valganciclovir.
abstract: We describe the case of an 18-year-old immunocompetent male patient with severe hepatitis during primary Epstein-Barr virus infection, treated with oral valganciclovir. During the initial therapy with corticosteroids, the patient's clinical condition and liver function worsened, so we decided to add oral valganciclovir for its good bio-availability and previous encouraging experiences in different clinical settings, with rapid resolution of the symptoms.
authors: Clinical Department, First Division, National Institute for Infectious Diseases "Lazzaro Spallanzani", Via Portuense 292, 00149, Rome, Italy.
authors: R
authors: R
authors: Pisapia
authors: A
authors: A
authors: Mariano
authors: A
authors: A
authors: Rianda
authors: A
authors: A
authors: Testa
authors: A
authors: A
authors: Oliva
authors: L
authors: L
authors: Vincenzi
mesh_terms: D000293:Adolescent; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D020031:Epstein-Barr Virus Infections / Q000175:diagnosis / Q000188:drug therapy*; D015774:Ganciclovir / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006525:Hepatitis, Viral, Human / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D016896:Treatment Outcome; D000077562:Valganciclovir
chemical_list: D000998:Antiviral Agents; D000077562:Valganciclovir; D015774:Ganciclovir